COVID-19 Medical Products Supply Chain Week in Review – February 2021 #1

Alston & Bird

In the past week, the Biden Administration has kept up the pace of issuing executive actions to address the COVID-19 pandemic. The following executive actions are worth noting for their potential impact on the medical product industry’s supply chains:

  1. Purchase 200 million additional doses of Pfizer and Moderna vaccines to be delivered this summer.
  2. Increase overall weekly vaccine supply to states, tribes, and territories from 8.6 million doses to a minimum of 10 million doses for the next three weeks.
  3. Provide states, tribes, and territories with a reliable three-week supply forecast.
  • On January 26, the FDA announced its decision to place all alcohol-based hand sanitizers from Mexico on a countrywide import alert until the agency is able to review the products’ safety. This action was due to a sharp increase in such products from Mexico that had tested positive for methanol contamination and marked the first countrywide import alert for any category of drug product.
  • On January 27, during its first press briefing, the White House COVID-19 Response Team indicated that it had identified 12 areas for possible invocation of the Defense Production Act, including the manufacture of masks and tests. The response team also indicated that the option to retrofit factories to mass produce other companies’ vaccine was “under active exploration.” See the Reuters news report here.
  • On February 3, the Subcommittee on Health of the House Committee on Energy and Commerce will hold a hearing, “Road to Recovery: Ramping Up COVID-19 Vaccines, Testing, and Medical Supply Chain.”

[View source.]

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Alston & Bird | Attorney Advertising

Written by:

Alston & Bird

Alston & Bird on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.